Changes in blood eosinophilia during omalizumab therapy as a predictor of asthma exacerbation
about
Biomarkers and severe asthma: a critical appraisalIgE-Related Chronic Diseases and Anti-IgE-Based Treatments.Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update.Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer.Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells.Biologic agents for severe asthma patients: clinical perspectives and implications.
P2860
Changes in blood eosinophilia during omalizumab therapy as a predictor of asthma exacerbation
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Changes in blood eosinophilia ...... edictor of asthma exacerbation
@en
type
label
Changes in blood eosinophilia ...... edictor of asthma exacerbation
@en
prefLabel
Changes in blood eosinophilia ...... edictor of asthma exacerbation
@en
P2093
P2860
P50
P356
P1476
Changes in blood eosinophilia ...... edictor of asthma exacerbation
@en
P2093
Roman Skiepko
Urszula Skiepko
Wojciech Budny
P2860
P304
P356
10.5114/PDIA.2014.40973
P577
2014-10-22T00:00:00Z